SEC Filing Details

Document Details

Form
Filing Date
Apr 30, 2026
Document Date
Apr 30, 2026
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Seaport Therapeutics
Issuer
SEAPORT THERAPEUTICS, INC.
Filer
ARCH VENTURE PARTNERS XII, LLC
Seaport Therapeutics Logo

© 2026 Seaport Therapeutics

Seaport Therapeutics Logo


© 2026 Seaport Therapeutics